Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical Trial

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389:1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Chronic Obstructive Pulmonary Disease Group of Respiratory Medicine Branch of Chinese Medical Association, Chronic Obstructive Pulmonary Disease Working Committee of Respiratory Physician Branch of Chinese Medical Doctor Association. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease (2021 revised edition). J Tuberc Respir. 2021;44(03):170–205.
   Google Scholar
• Hillas G, Perlikos F, Tzanakis N. Acute exacerbation of COPD: is it the “stroke of the lungs”? Int J Chron Obstruct Pulmon Dis. 2016;11:1579–1586. doi:10.2147/COPD.S106160
   PubMed Web of Science ®Google Scholar
• Ma J, Zheng J, Zhong N, et al. Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study. Int J Chron Obstruct Pulmon Dis. 2018;13:3107–3114. doi:10.2147/COPD.S170555
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhang H, Chen H. Effect of Yupingfeng granule on recurrent upper respiratory tract infection in children and its regulation on humoral immune function. Chin J Trad Chin Med. 2022;40(05):219–222.
   Google Scholar
• Guo W, He Y, Zhang X, Wen J, Liu Y. Modified Yupingfeng powder in adjuvant therapy of allergic rhinitis: asystematic review. China Pharm. 2017;28(21):2947–2950.
   Google Scholar
• Lin J, Sun Z. Guidelines for the clinical application of Chinese patent medicine in the treatment of adult bronchial asthma (2021). China J Integr Med. 2022;20:1–11. doi:10.1016/j.joim.2021.11.008
   Web of Science ®Google Scholar
• Liu H, Tian T, Wu Y, Tian L. Research progress of Yupingfeng Powder in the treatment of respiratory allergic diseases. J Tradit Chin Med Eye Otolaryngol. 2020;10:222–225.
   Google Scholar
• Fan C. Cost-effectiveness analysis of indacaterol and tiotropium bromide in the treatment of COPD under the cost environment of China. Drug Eval. 2016;13:34–39.
   Google Scholar
• Yaozhi. Drug winning database, Yupingfeng (April 29, 2020–December 16, 2020). Available from: https://www.yaozh.com. Accessed January 10, 2022.
   Google Scholar
• Zhou Y, Wang X, Zeng X, et al. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. Respirology. 2006;11:603–610. doi:10.1111/j.1440-1843.2006.00897.x
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhong N, Wang C, et al. The efficacy and safety of once-daily fluticasone furoate/umeclidinium/vilanterol versus twice-daily budesonide/formoterol in a subgroup of patients from China with symptomatic COPD at risk of exacerbations (FULFIL trial). COPD. 2018;15:334–340. doi:10.1080/15412555.2018.1481022
   PubMedGoogle Scholar
• Buxton KL, Roberts CM, Buckingham RJ, Pursey N, Stone RA. Palliative care service provision for chronic obstructive pulmonary disease patients: results from the 2008 national chronic obstructive pulmonary disease audit. In: Winter Meeting of the British-Thoracic-Society. London: Thorax; 2008:63.
   Google Scholar
• Lim J, Choi SE, Bae E, Kang D, Lim EA, Shin GS. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea. Health Qual Life Outcomes. 2019;17:97. doi:10.1186/s12955-019-1148-3
   PubMed Web of Science ®Google Scholar
• Liu G. China Guidelines for Pharmacoeconomic Evaluations. Beijing: Science Press; 2020.
   Google Scholar
• National Bureau of Statistics. The People’s Republic of China 2020 National economic and social development statistical bulletin; 2021. Available from: http://www.stats.gov.cn/tjsj/zxfb/202102/t20210227_1814154.html. Accessed February 28, 2021.
   Google Scholar
• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176:753–760. doi:10.1164/rccm.200612-1749OC
   PubMed Web of Science ®Google Scholar
• Rong J, Ge Y, Chen G, Wang L, Ding H. Meta-analysis of the prevalence of chronic obstructive pulmonary disease in Chinese adults aged 40 and over from 2010 to 2019. Mod Prev Med. 2020;47:2305–9+36.
   Google Scholar
• Zeng J, Deng Y, Ji K, Xu X, Cheng S. Study on the change trend of life expectancy and death spectrum of residents in Sichuan Province from 1989 to 2018. China Chronic Dis Prev Control. 2019;27:570–574.
   Google Scholar
• People’s Daily. National health supports all-round well-off; 2021. Available from: http://www.nhc.gov.cn/wjw/mtbd/202106/4842f687b131495ca9b2568caf0218fb.shtml. Accessed June 22, 2021.
   Google Scholar
• Zhang ZL, Li SN, Chen H, Luo T, Chen YL. Expression and influence of chemokine receptor 3 and lymphocyte subsets in different stages of chronic obstructive pulmonary disease. Hainan Med. 2017;28:3208–3210.
   Google Scholar
• Jue S, Jun L, Shirui Z, et al. Anti-inflammatory and immunoregulatory effects of yupingfeng powder on chronic bronchitis rats. Chin J Integr Med . 2013;2013(5):7.
   Google Scholar
• Huang A. Clinical efficacy and safety evaluation of budesonide combined with Yupingfeng granules in the treatment of bronchial asthma in children. J Mathematical Med 2018 [Chinese]. https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2018&filename=SLYY201803035&uniplatform=NZKPT&v=NefN0VZaSCizXhNkMdbY22qFfbJelw-ixZaxN1FNARExsjxDOp_qrN0-7j7WCdwp.
   Google Scholar
• Fan W, Zheng P, Wang Y, Hao P, Liu J, Zhao X. Analysis of immunostimulatory activity of polysaccharide extracted from Yu-Ping-Feng in vitro and in vivo. Biomed Pharmacother. 2017;93:146–155. doi:10.1016/j.biopha.2017.05.138
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng B, Tian H, et al. Yupingfeng Powder relieves the immune suppression induced by dexamethasone in mice. J Ethnopharmacol. 2017;200:117–123. doi:10.1016/j.jep.2017.01.054
   PubMed Web of Science ®Google Scholar
• Gao J, Li J, Shao X, et al. Antiinflammatory and immunoregulatory effects of total glucosides of Yupingfeng powder. Chin Med J. 2009;122(14):1636–1641.
   PubMed Web of Science ®Google Scholar
• Yang Z, Li L, Zhang X, et al. Effect of western medicine combined with Yupingfeng powder on airway inflammation and immune regulation in 58 cases of allergic rhinitis asthma syndrome. Chin Ethnic Folk Med. 2021;30(18):109–111, 118.
   Google Scholar
• Runfeng L, Yunlong H, Jicheng H, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020;156:104761. doi:10.1016/j.phrs.2020.104761
   PubMed Web of Science ®Google Scholar
• Hu K, Guan WJ, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2021;85:153242. doi:10.1016/j.phymed.2020.153242
   PubMed Web of Science ®Google Scholar
• Liu C, Liu T, Zhang J. On the cognitive process of new coronavirus pneumonia from the update of the new coronavirus pneumonia diagnosis and treatment guidelines. J Xi’an Jiaotong Univ. 2021;42:333–338.
   Google Scholar
• Jin Y, Zhan Q, Peng Z, et al. Evidence-based clinical practice guidelines for drug prevention, diagnosis, treatment and discharge management of novel coronavirus pneumonia (updated version). PLA Med J. 2020;45(10):1003–1031.
   Google Scholar
• Xiao M, Tian J, Zhou Y, et al. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial. Pharmacol Res. 2020;161:105126. doi:10.1016/j.phrs.2020.105126
   PubMed Web of Science ®Google Scholar
• Li JS, Xie Y, Li SY, Yu XQ. Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial. Trials. 2014;15:153. doi:10.1186/1745-6215-15-153
   PubMed Web of Science ®Google Scholar
• Xuan J, Lu Y, Liu B. Cost-effectiveness analysis of Yupingfeng granules in the treatment of children with recurrent respiratory tract infections. China Pharmacoecon. 2017;12(07):5–9.
   Google Scholar
• Zeng B, Cai G, He X. Clinical observation and pharmacoeconomic analysis of Danggui Liuhuang Decoction and Yupingfeng Powder in the treatment of post-chemotherapy hyperhidrosis. China Med Innov. 2008;5(34):1–2.
   Google Scholar